Researcher.Life Logo

Clinical Cancer Research : Impact Factor & More

eISSN: 1557-3265pISSN: 1078-0432

Aims and Scope of Clinical Cancer Research

Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research. Less

Key Metrics

CiteScore
19.8
Eigenfactor
0.1 - 0.5
H-Index
362
Impact Factor
10 - 15
Scite Index
0.90 5-Year SI
SJR
Q1Oncology
SNIP
2.43
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical Cancer Research

Clinical Cancer Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher AMER ASSOC CANCER RESEARCH
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year1995
Publisher URLVisit website
View less

Planning to publish in Clinical Cancer Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical Cancer Research

Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.
  • 19 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Lipid Nanoparticle-encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ Plus Durvalumab Induces an Immunostimulatory Effect Within the Tumor Microenvironment in Patients with Advanced Solid Tumors.
  • 18 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Phenotypic and Functional Characteristics of CD8+ T cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.
  • 18 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.
  • 18 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors.
  • 18 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial.
  • 18 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.
  • 19 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Lipid Nanoparticle-encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ Plus Durvalumab Induces an Immunostimulatory Effect Within the Tumor Microenvironment in Patients with Advanced Solid Tumors.
  • 18 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Phenotypic and Functional Characteristics of CD8+ T cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.
  • 18 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.
  • 18 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors.
  • 18 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear Cell Renal Cell Carcinoma: analyses of the HCRN GU16-260 trial.
  • 18 May 2026
  • Clinical cancer research : an official journal of the American Association for Cancer Research

FAQs on Clinical Cancer Research